Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Tissue Diagnostic Market Growth From $7.25 Billion In 2026 To $11.97 Billion By 2030 At A CAGR Of 13.4%
The tissue diagnostic market has demonstrated substantial growth in its size over recent years. Forecasts indicate that its value will escalate from $6.38 billion in 2025 to $7.25 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.6%. This historical expansion is attributable to several factors, including a rise in cancer diagnostic volumes, the expansion of hospital pathology laboratories, the increasing embrace of immunohistochemistry techniques, greater utilization of automated diagnostic instruments, and enhanced availability of sophisticated reagents.
The tissue diagnostic market size is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $11.97 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.4%. This growth during the projection period stems from factors such as heightened demand for precise diagnostic methods, the increasing embrace of AI-powered pathology instruments, the broadening scope of personalized medicine efforts, expanding capital allocation in digital health systems, and a sharpened emphasis on diagnostic precision and processing speed. Key developments expected within this period involve the greater uptake of digital pathology solutions, a surge in the application of automated tissue staining mechanisms, the increasing incorporation of AI-driven image analysis, the widening availability of multiplex tissue assessments, and a heightened commitment to optimizing workflow consistency.
Get A Free Sample Report With In-Depth Market Insights:
Tissue Diagnostic Market Development Factors: What’s Supporting Demand?
The increasing prevalence of cancer is set to drive the expansion of the tissue diagnostic market throughout the forecast period. This disease originates when genetic alterations disrupt normal cellular processes, leading to uncontrolled cell proliferation that damages bodily tissues and forms a mass known as a tumor, which can be either malignant or non-cancerous. Various factors contribute to cancer development, including genetic mutations, exposure to carcinogens (cancer-causing chemicals), smoking, excessive weight, radiation, hormonal influences, among others. With a growing number of cancer cases, there arises a crucial demand for diagnostic methods like tissue diagnostics to accurately identify the disease state. For example, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, projected more than 35 million new cancer cases in 2050, representing a 77% increase from the approximately 20 million cases recorded in 2022. Consequently, the escalating incidence of cancer fuels the growth of the tissue diagnostic market.
Tissue Diagnostic Market Segmentation And Category Overview
The tissue diagnostic market covered in this report is segmented –
1) By Product: Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System, Scanner, Tissue Processing system
2) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology And Workflow Management, Special Staining
3) By Disease: Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC)
4) By End User: Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations
Subsegments:
1) By Consumables: Biopsy Needles, Slides And Cover Slips, Tissue Embedding Materials
2) By Antibodies: Primary Antibodies, Secondary Antibodies, Monoclonal Antibodies, Polyclonal Antibodies
3) By Kits: Diagnostic Kits, Assay Kits, Staining Kits
4) By Reagents: Fixatives, Staining Reagents, Antigen Retrieval Solutions
5) By Probes: Fluorescent Probes, Molecular Probes, Hybridization Probes
6) By Instruments: Microscopes, Tissue Microarray Instruments, Laser Capture Microdissection Instruments
7) By Slide Staining System: Automated Stainers, Manual Staining Systems
8) By Scanner: Digital Slide Scanners, Whole Slide Imaging Systems
9) By Tissue Processing System: Tissue Processors, Embedding Centers, Microtomes
Tissue Diagnostic Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the tissue diagnostic market are prioritizing technological innovations, particularly the incorporation of artificial intelligence, to improve the accuracy and efficacy of prostate cancer diagnosis and treatment. This integration of AI in tissue diagnostics involves leveraging artificial intelligence algorithms to analyze and interpret medical images and pathological data, thereby enhancing the precision and speed of disease detection and classification. For instance, in March 2023, Qritive, a Singapore-based healthcare firm, introduced the Qai Prostate, an advanced artificial intelligence (AI)-powered tool designed to aid pathologists in detecting prostate cancer. The QAi prostate cancer diagnosis tool is utilized to pinpoint prostatic adenocarcinoma regions and categorize malignant and benign tumor locations within biopsy tissue samples. Subsequent to identification and classification, the program provides a comprehensive report that includes tumor size and the percentage for each slide or region of interest (ROI) specifically for adenocarcinoma screening.
Tissue Diagnostic Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the tissue diagnostic market are F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Zeiss Group AG
View The Full Tissue Diagnostic Market Report:
Tissue Diagnostic Market Geographic Distribution And Regional Opportunities
North America was the largest region in the tissue diagnostic market in 2025. The regions covered in the tissue diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
